Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care.
about
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patternsPrevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohortHIV pharmaceutical care in primary healthcare: Improvement in CD4 count and reduction in drug-related problemsReporting of critical information in studies of pharmacists in HIV careImpact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection.The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic reviewAntiretroviral drugs: critical issues and recent advancesPharmacist counseling in a cohort of women with HIV and women at risk for HIVPrevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda.Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infectionAntiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults.Antiretroviral Stewardship in a Pediatric HIV Clinic: Development, Implementation and Improved Clinical OutcomesPotential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria.Clinically significant drug interactions in younger and older human immunodeficiency virus-positive patients receiving antiretroviral therapy.Patients accessing HIV treatment via sexual health services: what are the risks of the dual case-note system?Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting.PHIRST Trial - pharmacist consults: prioritization of HIV-patients with a referral screening tool.Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes.Recognition of possible risk factors for clinically significant drug-drug interactions among Indian people living with HIV receiving highly active antiretroviral therapy and concomitant medications.Associated factors of drug-drug interactions of highly active antiretroviral therapy: report from a referral center.Identification of potential clinically significant drug interactions in HIV-infected patients: a comprehensive therapeutic approach.The clinical utility of HIV outpatient pharmacist prescreening to reduce medication error and assess adherence.Incidence of Antiretroviral Drug Interactions During Hospital Course: The Role of a Pharmacist-Led Antiretroviral Stewardship Program.
P2860
Q24234308-51175E62-D421-425C-8719-5460699379F6Q28477246-5A0915A7-7885-47C4-9762-D9CF3173C1BCQ33896762-1B583A4A-0A44-434D-8861-BDF913966452Q33955252-4E3D1928-23BA-4EE9-B269-84171CAFC4D0Q34034101-D53A7F4F-CACB-4215-8751-CB14F4976B5CQ35905941-0B1EB9F9-F44E-49E2-B56A-53E2C18D2126Q36020992-F1BC3FF6-897A-4B1C-9D0F-791F9D07B634Q36085773-8D1748BC-F8BA-41FF-A519-FD52823F408CQ36298965-9CC3022B-0437-44E3-9B70-500C1670FA54Q36320042-846446D5-90BC-4836-8680-5521E4248CDAQ36461597-09EF7BFF-2095-4A57-8023-DACAE367E57FQ36896555-9FAB7B40-CF11-4A42-90E4-CAEC75E42D23Q37696834-9530A6C8-BDB2-48F3-908D-FF76E0E48C52Q37933363-B79B4193-AB86-4687-A9D5-4BF3C1044AF5Q37994152-91853323-25FA-4D1C-8F56-C61C367DBBAFQ38037008-7158BFF2-75B2-49E6-B875-D49D67C8B0EEQ38671071-104CFB8A-F78C-4BE4-A8A6-DAB9AD9AE52FQ39418438-9B7A338D-0785-4B26-BAD5-C55ABA463421Q40051310-36F88465-7A74-456E-B03A-6ACD73AA0021Q41564295-F258D46A-CAA9-4F79-8F85-A385C10C5CDDQ41591785-8347C1F4-8F06-4635-B2C7-95B04C59F6EDQ44273051-9BB73834-787B-4440-A4E4-CC853EBD8C1FQ55186790-966A2F4B-EAA9-4A10-8775-94E066BEBEF0
P2860
Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Evaluation of clinical pharmac ...... tient pharmaceutical HIV-care.
@en
Evaluation of clinical pharmac ...... tient pharmaceutical HIV-care.
@nl
type
label
Evaluation of clinical pharmac ...... tient pharmaceutical HIV-care.
@en
Evaluation of clinical pharmac ...... tient pharmaceutical HIV-care.
@nl
prefLabel
Evaluation of clinical pharmac ...... tient pharmaceutical HIV-care.
@en
Evaluation of clinical pharmac ...... tient pharmaceutical HIV-care.
@nl
P2093
P2860
P1476
Evaluation of clinical pharmac ...... tient pharmaceutical HIV-care.
@en
P2093
Beijnen JH
Huitema AD
Mairuhu AT
Meenhorst PL
de Maat MM
van Gorp EC
P2860
P304
P356
10.1111/J.1365-2710.2003.00541.X
P577
2004-04-01T00:00:00Z